as on November 17, 2025 at 4:01 pm IST
Day's Low
Day's High
2.69%
Downside
0.77%
Upside
52 Week's Low
52 Week's High
48.11%
Downside
1.70%
Upside
as on November 17, 2025 at 4:01 pm IST
Market Cap
₹878.76 Cr
Return on Equity (ROE)
6.39
PE Ratio (TTM)
44.48
Return on capital employed (ROCE)
8.37
Industry PE ratio
42.22
Beta (LTM)
0.7
P/B Ratio
1.64
Dividend Yield
0PEG Ratio
14.03
Quarterly Earnings Growth YOY
-5.42
EPS (TTM)
7.97
Sector
Pharmaceuticals
Book Value
128.75
Technical Analysis
Bullish
View Technical Analysis
as on November 17, 2025 at 4:01 pm IST
Sakar Healthcare Ltd in the last 5 years
Lowest (13.06x)
May 12, 2022
Industry (42.22x)
November 14, 2025
Today (44.48x)
November 14, 2025
Highest (71.76x)
January 24, 2024
Today’s Price to Earnings Ratio: 44.48x
Compare market cap, revenue, PE, and other key metrics of Sakar Healthcare Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 878.76 | 80.56% | 0.62 | 17 | 177 | |
| NA | 464.59 | 18.91% | 0.00 | 17 | 345 | |
| NA | 92.63 | -1.88% | 0.00 | 2 | 44 | |
| 2,564.39 | -9.15% | 0.72 | -567 | 1,283 | ||
| NA | 21,863.32 | 76.23% | 0.68 | -57 | 3,012 |
Search interest for Sakar Healthcare Ltd Stock has increased by 197% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:197% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Sakar Healthcare Ltd.
Sakar Healthcare Ltd’s net profit fell -5.42% since last year same period to ₹4.54Cr in the Q2 2025-2026. On a quarterly growth basis, Sakar Healthcare Ltd has generated -2.78% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 6 quarters, 41.61 Cr → 58.78 Cr (in ₹), with an average increase of 6.6% per quarter
Price Rise
![]()
In the last 1 month, SAKAR stock has moved up by 12.4%
Best in 1 Year
![]()
In the last 1 year, SAKAR has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 52.86% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 135.4% return, outperforming this stock by 70.7%
Retail Holding Down
![]()
Retail Investor have decreased holdings from 22.48% to 22.41% in Sep 2025 quarter
Profit Down
![]()
Netprofit is down for the last 3 quarters, 5.76 Cr → 4.54 Cr (in ₹), with an average decrease of 10.9% per quarter
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 13.41% to 13.31% in Sep 2025 quarter
| Organisation | Sakar Healthcare Ltd |
| Headquarters | Ahmedabad |
| Industry | Pharmaceuticals |
| CEO | Sanjay S Shah. |
| E-voting on shares | Click here to vote |
Sakar Healthcare Ltd share price today stands at ₹404.9 as on at the close of the market. Sakar Healthcare Ltd share today touched a day high of ₹408 and a low of ₹394.
Sakar Healthcare Ltd touched a 52 week high of ₹411.8 and a 52 week low of ₹210.1. Sakar Healthcare Ltd share price today i.e. is closed at ₹404.9, which is -1.68% down from its 52 week high and 92.72% up from its 52 week low.
Sakar Healthcare Ltd market capitalisation is ₹878.76 Cr as on .
To buy Sakar Healthcare Ltd shares, you need to follow these steps:
Sakar Healthcare Ltd trading volume is 14.40K as on . This means that 14.40K shares of Sakar Healthcare Ltd were bought and sold on the stock market during today's trading session.